Cancer drugs
Revolution Medicines gets FDA approval for targeted pancreatic cancer drug
Revolution said the drug is now available in the United States at $39,800 for a 30-day supply. The company added that it would make assistance available as well.
Israeli scientists launch worlds-first clinical trial for experimental pancreatic cancer treatment
Tel Aviv University study reveals how tumors hijack immune cells to fuel cancer growth and spread
Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim
Special drug class could be used to reverse damage from radiotherapy - study
By testing senolytic drugs on mice, researchers found that those treated shortly after radiotherapy did not suffer from premature aging.
The future of personalized medicine is already in Israel
Progenetics, founded by Manaster in 2015, bridges the gap between standard medicine and the cutting-edge oncological diagnostic services available today.
Israeli company wins license to develop plant-based cancer treatment
The company recently reported that one of its products assisted in killing breast cancer cells by up to six times the amount of current treatments.
Israeli research institute makes great contributions to cancer research
Technologies including artificial intelligence-based diagnostic software may be changing how the disease is detected and treated in the future.
Weizmann study identifies genes connected to myeloma drug resistance
The Weizmann team found that they could silence one of the genes responsible for drug resistance to help make drugs more effective.
Canadian fund for Israel cancer research announced $1 million donation
"This extraordinary gift will make a real difference in the fight against female reproductive cancers," assured Bryna Goldberg, ICRF's international chairwoman.
Tamir Gilat turns a death sentence into a life with meaning
“I was living from holiday to holiday – from Hanukkah to Passover, from Passover to Shavuot."
Calm, comfortable cancer treatment at Place2Heal
Place2Heal is transforming Israel’s outpatient cancer treatment centers into less stressful, even tranquil spaces
FDA gives Jerusalem-based company go-ahead to start cancer drug trials
The drug, DSP107 works by both boosting the body's natural immune system, and breaking down the defenses of the cancer cells.
![Cancer cells [illustrative]](https://images.jpost.com/image/upload/f_auto,fl_lossy/q_auto/c_fill,g_faces:center,h_194,w_290/434955 "Cancer cells [illustrative]")
Could a study of sea urchins help scientists develop new cancer drugs?
The team showed that the sea urchin’s anatomy is not only physically but genetically analogous to humans’ anatomy.
